Risks, Rules, & Reels: FDA-Compliant Ad Campaigns

September 25, 2026 | 12:00PM–1:30PM ET | Live Webinar

Register Now Risks, Rules, & Reels: FDA-Compliant Ad Campaigns September 25, 2026, 12:00-1:30PM ET | Live Webinar

Overview

This webinar covers FDA and advertising law compliance for social media and virtual platform advertising across all regulated products. Panelists will discuss influencer campaigns, expert collaborations, and user-generated content, emphasizing sponsor responsibility, sponsorship disclosure, and risk communication across platforms and populations. Discover practical approaches for approving scripts, handling risk presentation across formats, and reporting adverse events to stay compliant amid FDA and FTC scrutiny of online promotions. Panelists will also address risks associated with generative AI in ad campaigns and the implications of recent litigation shaping platform liability and compliance strategies for FDA-regulated products.

$149

Members

$249

Non-Members

Speakers

Heather Bañuelos
Read Bio
Counsel, King & Spalding LLP

Alicia Kantor
Read Bio
Legal Counsel – Enterprise Legal Regulatory, Medtronic

Robert N. Merrill
Read Bio
Co-Managing Partner, ProPharma Group

Duane C. Pozza
Read Bio
Partner, Wiley LLP

FDLI applies for CLE credits in Ohio and Virginia. These CLE approvals also may be honored by other states. The CLE credits will be posted as they are granted and registrants can request to be notified when approval is received.